386 related articles for article (PubMed ID: 27089238)
1. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy.
Lukey MJ; Greene KS; Erickson JW; Wilson KF; Cerione RA
Nat Commun; 2016 Apr; 7():11321. PubMed ID: 27089238
[TBL] [Abstract][Full Text] [Related]
2. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.
Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G
Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759
[TBL] [Abstract][Full Text] [Related]
3. c-Myc Overexpression Promotes Oral Cancer Cell Proliferation and Migration by Enhancing Glutaminase and Glutamine Synthetase Activity.
Wang T; Cai B; Ding M; Su Z; Liu Y; Shen L
Am J Med Sci; 2019 Sep; 358(3):235-242. PubMed ID: 31324362
[TBL] [Abstract][Full Text] [Related]
4. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.
Wang JB; Erickson JW; Fuji R; Ramachandran S; Gao P; Dinavahi R; Wilson KF; Ambrosio AL; Dias SM; Dang CV; Cerione RA
Cancer Cell; 2010 Sep; 18(3):207-19. PubMed ID: 20832749
[TBL] [Abstract][Full Text] [Related]
5. Aging Reduces an ERRalpha-Directed Mitochondrial Glutaminase Expression Suppressing Glutamine Anaplerosis and Osteogenic Differentiation of Mesenchymal Stem Cells.
Huang T; Liu R; Fu X; Yao D; Yang M; Liu Q; Lu WW; Wu C; Guan M
Stem Cells; 2017 Feb; 35(2):411-424. PubMed ID: 27501743
[TBL] [Abstract][Full Text] [Related]
6. The proto-oncogene JUN is a target of the heat shock transcription factor HSF1.
Sawai M; Ishikawa Y; Ota A; Sakurai H
FEBS J; 2013 Dec; 280(24):6672-80. PubMed ID: 24127737
[TBL] [Abstract][Full Text] [Related]
7. Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer.
Lukey MJ; Cluntun AA; Katt WP; Lin MJ; Druso JE; Ramachandran S; Erickson JW; Le HH; Wang ZE; Blank B; Greene KS; Cerione RA
Cell Rep; 2019 Oct; 29(1):76-88.e7. PubMed ID: 31577957
[TBL] [Abstract][Full Text] [Related]
8. The NF-κB member p65 controls glutamine metabolism through miR-23a.
Rathore MG; Saumet A; Rossi JF; de Bettignies C; Tempé D; Lecellier CH; Villalba M
Int J Biochem Cell Biol; 2012 Sep; 44(9):1448-56. PubMed ID: 22634383
[TBL] [Abstract][Full Text] [Related]
9. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.
Shen YA; Hong J; Asaka R; Asaka S; Hsu FC; Suryo Rahmanto Y; Jung JG; Chen YW; Yen TT; Tomaszewski A; Zhang C; Attarwala N; DeMarzo AM; Davidson B; Chuang CM; Chen X; Gaillard S; Le A; Shih IM; Wang TL
Cancer Res; 2020 Oct; 80(20):4514-4526. PubMed ID: 32859605
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.
Xiang Y; Stine ZE; Xia J; Lu Y; O'Connor RS; Altman BJ; Hsieh AL; Gouw AM; Thomas AG; Gao P; Sun L; Song L; Yan B; Slusher BS; Zhuo J; Ooi LL; Lee CG; Mancuso A; McCallion AS; Le A; Milone MC; Rayport S; Felsher DW; Dang CV
J Clin Invest; 2015 Jun; 125(6):2293-306. PubMed ID: 25915584
[TBL] [Abstract][Full Text] [Related]
12. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of glutaminase K and L isoenzymes in human tumour cells.
Pérez-Gómez C; Campos-Sandoval JA; Alonso FJ; Segura JA; Manzanares E; Ruiz-Sánchez P; González ME; Márquez J; Matés JM
Biochem J; 2005 Mar; 386(Pt 3):535-42. PubMed ID: 15496140
[TBL] [Abstract][Full Text] [Related]
14. LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression.
Zhou Q; Zhan H; Lin F; Liu Y; Yang K; Gao Q; Ding M; Liu Y; Huang W; Cai Z
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30902882
[TBL] [Abstract][Full Text] [Related]
15. p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells.
Leaner VD; Donninger H; Ellis CA; Clark GJ; Birrer MJ
Mol Cell Biol; 2005 Apr; 25(8):3324-37. PubMed ID: 15798216
[TBL] [Abstract][Full Text] [Related]
16. Molecular targets of the oncogenic transcription factor jun.
Hartl M; Bader AG; Bister K
Curr Cancer Drug Targets; 2003 Feb; 3(1):41-55. PubMed ID: 12570660
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases.
Berenjeno IM; Núñez F; Bustelo XR
Oncogene; 2007 Jun; 26(29):4295-305. PubMed ID: 17213802
[TBL] [Abstract][Full Text] [Related]
18. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells.
Tong Y; Guo D; Lin SH; Liang J; Yang D; Ma C; Shao F; Li M; Yu Q; Jiang Y; Li L; Fang J; Yu R; Lu Z
Mol Cell; 2021 Jun; 81(11):2303-2316.e8. PubMed ID: 33991485
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.
Gaglio D; Metallo CM; Gameiro PA; Hiller K; Danna LS; Balestrieri C; Alberghina L; Stephanopoulos G; Chiaradonna F
Mol Syst Biol; 2011 Aug; 7():523. PubMed ID: 21847114
[TBL] [Abstract][Full Text] [Related]
20. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]